Among renal syndromes caused by glomerular disorders, FSGS continues to pose the most challenges in understanding its pathogenesis and therefore, in arriving at mechanism-based approaches for its treatment. The extraordinary diversity of genetic etiologies linked to primary FSGS, the sizable number of patients with idiopathic disease, and the disparate clinical conditions unrelated to primary FSGS that manifest the pathology of secondary FSGS make it difficult to formulate a unifying theory of pathogenesis. 1,2 The common feature that links together diverse genetically determined FSGS, idiopathic FSGS, and other toxic, infective, metabolic, and hemodynamic disorders that cause secondary FSGS is, of course, segmental and global scarring of glomeruli, a pathology now linked to development of podocytopathy. 1,2 Pathologic features can vary among the gamut of primary and secondary FSGS, but research points to the podocyte as the seat of early as well as continuing responsible pathology. According to evolving dogma, decrease in absolute podocyte numbers primarily, such as in oligomeganephronia, secondarily, through nephron loss by disease, or by cell death during disease is a major factor that fosters progressive glomerular damage. In this line of reasoning, podocytes decrease in number either relatively with respect to the demands of glomerular hypertrophy-such as in remnant kidneys after nephron loss by disease-or by cell death through disease-associated podocytopathy. As a result, remaining podocytes cannot adequately cover the outer surfaces of glomerular capillaries with the differentiated protoplasm required for structural integrity and barrier function. 3,4 In large part, this is caused by the inability of terminally differentiated podocytes to replenish the population through cell division. 4 Being possessed of unique structural and biologic attributes that make them vulnerable, surviving podocytes seem unable to adapt and withstand the hemodynamic, metabolic, aging, or disease-related stresses imposed on them or the stresses of pathologic signaling, oxidant injury, misfolded protein responses, cytoskeletal perturbations, or intracellular proteolysis-abnormalities caused by specific genetic mutations or other disease. If extreme, such stresses cause podocytopathy, cell death, additional podocyte depletion, and secondary endocapillary and mesangial pathologies characteristic of the sclerotic lesion. This pathology progresses segmentally and globally in autonomous vicious cycles: locally within glomeruli, serially injuring and killing adjacent podocytes, and through systemic effects, recruiting more glomeruli to the sclerotic process. [4][5][6] Because the instigating factors that cause secondary FSGS are so disparate and the genetic abnormalities that underlie primary FSGS are so unrelated to each other-affecting proteins related to slit diaphragms, cation channels, mitochondrial proteins, or cytoskeletal proteins-the question arises: is there a common cellular process that connects them, possibly as a final c...